Cigna · Zepbound and Wegovy coverage

Does Cigna cover Zepbound or Wegovy?

Last updated

Many Cigna plans exclude weight-loss drugs; covered plans need prior authorization.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Many Cigna plans exclude weight-loss drugs; covered plans need prior authorization. Cigna says weight-loss drugs are specifically excluded under many of its benefit plans, both employer and individual plans, so coverage depends on the plan document. In its words: "Weight loss medications are specifically excluded under many benefit plans [both Employer Groups and Individual and Family Plans]. Please refer to the applicable benefit plan document to determine benefit availability and the terms and conditions of coverage." (Cigna Drug Coverage Policy IP0621, Weight Loss - Glucagon-Like Peptide-1 Agonists BMI ≥ 32, effective 04/30/2026, static.cigna.com, read Nov 17, 2026). Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. In its words: "A) Initial Therapy. Approve for 8 months if the patient meets ALL of the following (i, ii, iii, and iv): i. Patient is ≥ 18 years of age; AND ii. Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Cigna's benefit-exclusion override product lets a plan that excludes weight-loss drugs still cover Zepbound for weight loss at a BMI of 35 or more, or 27 or more with at least two weight-related conditions. In its words: "This Benefit Exclusion Overrides policy has been developed to authorize coverage of Zepbound for the treatment of weight loss in adults with a body mass index (BMI) of ≥ 27 kg/m2 with at least two weight-related comorbidities, or with a body mass index of ≥ 35 kg/m2." (Cigna Drug Coverage Policy BEO014, Zepbound Benefit Exclusion Overrides Policy BMI ≥ 35, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Reported by Reuters (Cigna's own announcement to its employees, confirmed by a Cigna spokesperson): Cigna stopped covering weight-loss GLP-1s in its own employee health plan from July 1, 2026; the spokesperson said plans outside that employee plan are not affected. In its words: "Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, in its employee health plan effective July 1, according to materials viewed by Reuters." (Reuters (Amina Niasse), Cigna drops coverage of GLP-1 obesity drugs for its own employees, republished by InsuranceNewsNet, insurancenewsnet.com, Jul 1, 2026, read Nov 17, 2026).

Questions

Cigna, Zepbound and Wegovy: common questions

Does Cigna cover Zepbound for weight loss?

Many Cigna plans exclude weight-loss drugs; covered plans need prior authorization. Cigna says weight-loss drugs are specifically excluded under many of its benefit plans, both employer and individual plans, so coverage depends on the plan document. In its words: "Weight loss medications are specifically excluded under many benefit plans [both Employer Groups and Individual and Family Plans]. Please refer to the applicable benefit plan document to determine benefit availability and the terms and conditions of coverage." (Cigna Drug Coverage Policy IP0621, Weight Loss - Glucagon-Like Peptide-1 Agonists BMI ≥ 32, effective 04/30/2026, static.cigna.com, read Nov 17, 2026). Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. In its words: "A) Initial Therapy. Approve for 8 months if the patient meets ALL of the following (i, ii, iii, and iv): i. Patient is ≥ 18 years of age; AND ii. Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Cigna's benefit-exclusion override product lets a plan that excludes weight-loss drugs still cover Zepbound for weight loss at a BMI of 35 or more, or 27 or more with at least two weight-related conditions. In its words: "This Benefit Exclusion Overrides policy has been developed to authorize coverage of Zepbound for the treatment of weight loss in adults with a body mass index (BMI) of ≥ 27 kg/m2 with at least two weight-related comorbidities, or with a body mass index of ≥ 35 kg/m2." (Cigna Drug Coverage Policy BEO014, Zepbound Benefit Exclusion Overrides Policy BMI ≥ 35, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Reported by Reuters (Cigna's own announcement to its employees, confirmed by a Cigna spokesperson): Cigna stopped covering weight-loss GLP-1s in its own employee health plan from July 1, 2026; the spokesperson said plans outside that employee plan are not affected. In its words: "Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, in its employee health plan effective July 1, according to materials viewed by Reuters." (Reuters (Amina Niasse), Cigna drops coverage of GLP-1 obesity drugs for its own employees, republished by InsuranceNewsNet, insurancenewsnet.com, Jul 1, 2026, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does Cigna cover Wegovy for weight loss?

Many Cigna plans exclude weight-loss drugs; covered plans need prior authorization. Cigna says weight-loss drugs are specifically excluded under many of its benefit plans, both employer and individual plans, so coverage depends on the plan document. In its words: "Weight loss medications are specifically excluded under many benefit plans [both Employer Groups and Individual and Family Plans]. Please refer to the applicable benefit plan document to determine benefit availability and the terms and conditions of coverage." (Cigna Drug Coverage Policy IP0621, Weight Loss - Glucagon-Like Peptide-1 Agonists BMI ≥ 32, effective 04/30/2026, static.cigna.com, read Nov 17, 2026). Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. In its words: "A) Initial Therapy. Approve for 8 months if the patient meets ALL of the following (i, ii, iii, and iv): i. Patient is ≥ 18 years of age; AND ii. Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Cigna's benefit-exclusion override product lets a plan that excludes weight-loss drugs still cover Zepbound for weight loss at a BMI of 35 or more, or 27 or more with at least two weight-related conditions. In its words: "This Benefit Exclusion Overrides policy has been developed to authorize coverage of Zepbound for the treatment of weight loss in adults with a body mass index (BMI) of ≥ 27 kg/m2 with at least two weight-related comorbidities, or with a body mass index of ≥ 35 kg/m2." (Cigna Drug Coverage Policy BEO014, Zepbound Benefit Exclusion Overrides Policy BMI ≥ 35, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Reported by Reuters (Cigna's own announcement to its employees, confirmed by a Cigna spokesperson): Cigna stopped covering weight-loss GLP-1s in its own employee health plan from July 1, 2026; the spokesperson said plans outside that employee plan are not affected. In its words: "Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound, in its employee health plan effective July 1, according to materials viewed by Reuters." (Reuters (Amina Niasse), Cigna drops coverage of GLP-1 obesity drugs for its own employees, republished by InsuranceNewsNet, insurancenewsnet.com, Jul 1, 2026, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

Does Cigna cover Zepbound for sleep apnea?

Cigna covers Zepbound for moderate to severe obstructive sleep apnea in adults with a baseline BMI of 30 or more when a sleep study shows an AHI or respiratory event index of at least 15 per hour. In its words: "iii. Patient has had a sleep study that shows BOTH of the following (a and b): a) Patient has been diagnosed with moderate to severe obstructive sleep apnea; AND b) Patient meets ONE of the following [(1) or (2)]: (1)Patient has an apnea-hypopnea index ≥ 15 events per hour; OR (2)Patient has a respiratory event index ≥ 15 events per hour; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026).

Does Cigna cover Wegovy for heart disease?

Cigna covers Wegovy injection for cardiovascular risk reduction for one year in adults with established cardiovascular disease and a baseline BMI of 27 or more. In its words: "Major Adverse Cardiovascular Event(s) Risk Reduction in a Patient with Established Cardiovascular Disease with Overweight or Obesity. Approve for 1 year if the patient meets ALL of the following (A, B, C, D, and E): A) Patient is ≥ 18 years of age; AND B) At baseline, patient had a BMI ≥ 27 kg/m2; AND" (Cigna Drug Coverage Policy IP0814, Weight Loss - Glucagon-Like Peptide-1 Agonists - Wegovy Injection, effective 09/01/2026, static.cigna.com, read Nov 17, 2026).

What do Zepbound and Wegovy cost if Cigna does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.